Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Allarity Therapeutics, Inc.

NASDAQ: ALLR · Life Sciences · 8 alerts · CIK 1860657

Share price
$0.8752Close, Nov 16
Market cap
$14M
Shares outstanding
16MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Allarity Therapeutics, Inc. filings on SEC EDGAR ↗

7:51 AM ET 8-K
Loan & Debt

Allarity Therapeutics $3M Debt Financing with Streeterville Capital, LLC

Allarity Therapeutics entered into an exchange agreement with Streeterville Capital to partition $3.0 million from an existing $10.93 million promissory note. The partitioned debt was exchanged for 3,000 shares of newly designated Series B Preferred Stock, effectively reducing the company's outstanding debt balance by $3.0 million. The Series B Preferred Stock carries a 9% annual dividend and ranks senior to common stock in liquidation.

Value
$3M
Counterparty
Streeterville Capital, LLC
8:06 AM ET 10-Q
Financial Results

Allarity Therapeutics Q3 2026 Results: Net Loss of $6.2M, Loss Widens

For the nine months ended September 30, 2026, Allarity Therapeutics reported a net loss of $12.4 million, an increase from the $7.9 million loss in the prior year period, primarily driven by higher research and development costs. The company's total stockholders' equity turned to a deficit of $2.3 million as of September 30, 2026, while cash and restricted cash increased to approximately $24.1 million.

Key figure
Net loss $6.2M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.